Cargando…
Detection fidelity of AR mutations in plasma derived cell-free DNA
Somatic genetic alterations including copy number and point mutations in the androgen receptor (AR) are associated with resistance to therapies targeting the androgen/AR axis in patients with metastatic castration resistant prostate cancer (mCRPC). Due to limitations associated with biopsying metast...
Autores principales: | Goldstein, Alexa, Toro, Patricia Valda, Lee, Justin, Silberstein, John L., Nakazawa, Mary, Waters, Ian, Cravero, Karen, Chu, David, Cochran, Rory L., Kim, Minsoo, Shinn, Daniel, Torquato, Samantha, Hughes, Robert M., Pallavajjala, Aparna, Carducci, Michael A., Paller, Channing J., Denmeade, Samuel R., Kressel, Bruce, Trock, Bruce J., Eisenberger, Mario A., Antonarakis, Emmanuel S., Park, Ben H., Hurley, Paula J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362513/ https://www.ncbi.nlm.nih.gov/pubmed/28152506 http://dx.doi.org/10.18632/oncotarget.14926 |
Ejemplares similares
-
Genetic Alterations Detected in Cell-Free DNA Are Associated With Enzalutamide and Abiraterone Resistance in Castration-Resistant Prostate Cancer
por: Torquato, Samantha, et al.
Publicado: (2019) -
The effect of the frequency and duration of prostate specific antigen (PSA) measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer
por: Paller, CJ, et al.
Publicado: (2013) -
Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer
por: Paller, Channing J, et al.
Publicado: (2011) -
Radiation Therapy in the Definitive Management of Oligometastatic Prostate Cancer: The Johns Hopkins Experience
por: Deek, Matthew P., et al.
Publicado: (2019) -
A Review of Pomegranate in Prostate Cancer
por: Paller, Channing J., et al.
Publicado: (2017)